Division of Nephrology, San Francisco VA Medical Center/University of California, San Francisco, California, USA.
Center for Vascular Excellence, Division of Cardiology, San Francisco General Hospital/University of California, San Francisco, California, USA.
Hemodial Int. 2022 Jul;26(3):323-334. doi: 10.1111/hdi.13008. Epub 2022 Apr 6.
We lack cardiovascular (CV) markers for patients with end-stage renal disease (ESRD), and left atrial (LA) strain has not been studied definitively in this population. We examined associations of LA reservoir, conduit, and booster strain with major adverse cardiovascular events (MACE) among stable patients with ESRD on dialysis.
One hundred and ninety patients in the Cardiac, Endothelial and Arterial Stiffness in ESRD study underwent echocardiography, including strain imaging. The primary outcome was 2-year composite non-fatal MACE or CV death. We performed Cox proportional hazards regression for LA strain measures, adjusting for demographics, comorbidities, left ventricular global longitudinal strain (LV GLS), E/e' and LA volume index.
Mean ± SD LA reservoir strain was 24.1 ± 7.0%, and LA conduit strain 11.9 ± 5.1%. In age-adjusted analyses, lower LA reservoir strain and LA conduit strain were associated with the primary outcome (HR per 1-SD worsening LA strain parameter = 1.57 [95% CI 1.2-2.1], p = 0.003 and 1.68 [95% CI 1.2-2.3], p = 0.002, respectively). After adjusting for comorbidities, LA reservoir strain remained associated with the primary outcome and with deaths alone, and LA conduit strain with the primary outcome and hospitalizations alone (p < 0.05 for all). Associations of LA conduit strain were independent of LV GLS. Associations were stronger in participants with serum albumin <3.6 mg/dl (p for interaction 0.008).
Left atrial reservoir strain and conduit strain were independently associated with MACE among patients with ESRD. Our study provides unique ascertainment of CV hospitalizations not attributed to missed dialysis, and LA conduit strain was a strong marker for this outcome.
我们缺乏终末期肾病(ESRD)患者的心血管(CV)标志物,左心房(LA)应变在该人群中也尚未得到明确研究。我们研究了稳定的透析 ESRD 患者的 LA 储备、输送和助推应变与主要不良心血管事件(MACE)之间的相关性。
心脏、内皮和动脉僵硬在 ESRD 研究中的 190 名患者接受了超声心动图检查,包括应变成像。主要结局是 2 年复合非致命性 MACE 或心血管死亡。我们对 LA 应变指标进行 Cox 比例风险回归,调整了人口统计学、合并症、左心室整体纵向应变(LV GLS)、E/e'和 LA 容积指数。
平均 ± SD LA 储备应变 24.1 ± 7.0%,LA 输送应变 11.9 ± 5.1%。在年龄调整分析中,较低的 LA 储备应变和 LA 输送应变与主要结局相关(每 1-SD 恶化 LA 应变参数的 HR 分别为 1.57[95%CI 1.2-2.1],p=0.003 和 1.68[95%CI 1.2-2.3],p=0.002)。在调整合并症后,LA 储备应变仍与主要结局和单独死亡相关,LA 输送应变与主要结局和单独住院相关(所有 p<0.05)。LA 输送应变的相关性独立于 LV GLS。在血清白蛋白 <3.6 mg/dl 的参与者中,相关性更强(交互作用的 p 值为 0.008)。
LA 储备应变和输送应变与 ESRD 患者的 MACE 独立相关。我们的研究提供了对归因于漏诊透析的 CV 住院的独特确定,并且 LA 输送应变是该结果的强有力标志物。